Table 3.
Clinical diagnoses, pathomorphological diagnoses and physical forms of lesions
| Variable | N (%) |
|---|---|
| Clinical diagnosis: | |
| Papilloma | 22 (10.4) |
| Carcinoma | 1 (0.5) |
| Granuloma teleangiectaticum | 1 (0.5) |
| Tumour mixtus | 1 (0.5) |
| Leukoplakia | 17 (8.0) |
| Lichen planus | 1 (0.5) |
| Mucocele | 36 (17.0) |
| Mucogranuloma | 1 (0.5) |
| Epulis | 20 (9.4) |
| Epulis inflamatoria | 1 (0.5) |
| Neurofibroma | 1 (0.5) |
| Ulceration | 2 (0.9) |
| Ranula | 1 (0.5) |
| Fibroma | 75 (35.4) |
| Granuloma fissuratum | 22 (10.4) |
| Metastases | 1 (0.5) |
| Pathomorphological diagnosis: | |
| Papilloma | 16 (7.5) |
| Carcinoma planoepitheliale | 2 (0.9) |
| Dysplasia | 4 (1.9) |
| Tumour mixtus | 1 (0.5) |
| Leukoplakia | 6 (2.8) |
| Lichen planus | 4 (1.9) |
| Mucocele | 30 (14.2) |
| Mucogranuloma | 4 (1.9) |
| Haemangioma cavernosum | 1 (0.5) |
| Angiofibroma | 3 (1.4) |
| Neurofibroma | 2 (0.9) |
| Ulceration | 1 (0.5) |
| Ranula | 1 (0.5) |
| Lipofibroma | 1 (0.5) |
| Fibroma | 35 (16.5) |
| Irritation fibroma IF | 26 (12.3) |
| Inflammatory fibrous hyperplasia IFH | 3 (1.4) |
| Inflammatory papillary hyperplasia IPH | 3 (1.4) |
| Granuloma | 13 (6.1) |
| Granuloma teleangiectaticum | 8 (3.8) |
| Peripheral giant cell granuloma PGCG | 3 (1.4) |
| Pyogenic granuloma PG | 2 (0.9) |
| Granuloma fissuratum FG | 15 (7.1) |
| Lichenoid lesion | 12 (5.4) |
| Lichenoid lesion with inflammation | 10 (4.5) |
| Metastasis | 1 (0.9) |
| Physical form of the lesion: | |
| Nodule | 151 (71.2) |
| Ulceration | 2 (0.9) |
| Bulla | 37 (17.5) |
| Macula | 6 (2.8) |
| Plaque | 11 (5.2) |
| Drugs: | 198 (93.4) |
| Anticoagulants | 1 (0.5) |
| Anticonvulsants | 1 (0.5) |
| Antiplatelet drugs | 5 (2.5) |
| Steroids | 2 (1.0) |
| Benzodiazepines | 1 (0.5) |
| Thyroxine analogue | 4 (1.9) |
| Angiotensin-converting enzyme inhibitor | 1 (0.5) |